ARCHIVES

BSA Approves Trial of Carbon Ion Therapy, Extends EDRN And Provocative Questions

This article is from The Cancer Letter archive.

Vol. 40 No. 27 | July 4, 2014

Download PDF Visit The Full Archive

Related Articles

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

Surgeon General plans new report, database, on tobacco.

January 16, 2004

Nevins Retracts Key Paper By Duke Group, Raising Question Of Harm To Patients

October 29, 2010

AACR Opposes Human Life Bill; ASCO Backs Cancer Act, Reimbursement

May 8, 1981

Minority CCOP Applications Not Yet Reviewed

December 15, 1989

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001